Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
293.54 USD | -1.42% |
|
+2.84% | +12.62% |
Feb. 06 | Daiwa Securities Adjusts Amgen's Price Target to $350 From $360 | MT |
Feb. 06 | Trump faces pressure from US industry over China tariff on medicines | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration